These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16075304)

  • 1. Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism.
    Prathipati P; Saxena AK
    J Comput Aided Mol Des; 2005 Feb; 19(2):93-110. PubMed ID: 16075304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical virtual screening: identification of potential high-affinity and selective β(3)-adrenergic receptor agonists.
    Saxena AK; Roy KK
    SAR QSAR Environ Res; 2012 Jul; 23(5-6):389-407. PubMed ID: 22452658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations.
    Tewatia P; Agrawal N; Gaur M; Sahi S
    Biochimie; 2014 Jun; 101():168-82. PubMed ID: 24508605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of 3D-QSAR models in cyclic ureidobenzenesulfonamides: human beta3-adrenergic receptor agonist.
    Kashaw SK; Rathi L; Mishra P; Saxena AK
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2481-4. PubMed ID: 12852947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and simulation studies of human β3 adrenergic receptor and its interactions with agonists.
    Sahi S; Tewatia P; Malik BK
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):283-95. PubMed ID: 22242799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into β
    Luan J; Hu B; Wang H; Liu H; Wang S; Chen L; Li W; Wang J; Cheng M
    Comput Biol Chem; 2023 Jun; 104():107836. PubMed ID: 36889141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel β3-adrenoceptor agonists using energetic analysis, structure based pharmacophores and virtual screening.
    Tewatia P; Malik BK; Sahi S
    Comb Chem High Throughput Screen; 2012 Sep; 15(8):623-40. PubMed ID: 22375887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore-guided Virtual Screening to Identify New β
    Ujiantari NSO; Ham S; Nagiri C; Shihoya W; Nureki O; Hutchinson DS; Schuster D
    Mol Inform; 2022 Jul; 41(7):e2100223. PubMed ID: 34963040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in the design of orally bioavailable beta3-adrenergic receptor agonists.
    Sawa M; Harada H
    Curr Med Chem; 2006; 13(1):25-37. PubMed ID: 16457637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR analysis of thiazole benzenesulfonamide substituted 3-pyridylethanolamines as beta3-adrenergic receptor agonist.
    Hanumantharao P; Sambasivarao SV; Soni LK; Gupta AK; Kaskhedikar SG
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3167-73. PubMed ID: 15908203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aegeline inspired synthesis of novel β3-AR agonist improves insulin sensitivity in vitro and in vivo models of insulin resistance.
    Rajan S; Satish S; Shankar K; Pandeti S; Varshney S; Srivastava A; Kumar D; Gupta A; Gupta S; Choudhary R; Balaramnavar VM; Narender T; Gaikwad AN
    Metabolism; 2018 Aug; 85():1-13. PubMed ID: 29524448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology and pathophysiology of the β
    Yang LK; Tao YX
    Prog Mol Biol Transl Sci; 2019; 161():91-112. PubMed ID: 30711031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats.
    Gómez-Ambrosi J; Frühbeck G; Aguado M; Milagro FI; Margareto J; Martínez AJ
    Int J Mol Med; 2001 Jul; 8(1):103-9. PubMed ID: 11408957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.
    Wada Y; Shirahashi H; Iwanami T; Ogawa M; Nakano S; Morimoto A; Kasahara K; Tanaka E; Takada Y; Ohashi S; Mori M; Shuto S
    J Med Chem; 2015 Aug; 58(15):6048-57. PubMed ID: 26125514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
    Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
    J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.
    Igawa Y; Yamazaki Y; Takeda H; Hayakawa K; Akahane M; Ajisawa Y; Yoneyama T; Nishizawa O; Andersson KE
    Br J Pharmacol; 1999 Feb; 126(3):819-25. PubMed ID: 10188996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
    Liu J; Pan D; Tseng Y; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(6):2170-9. PubMed ID: 14632469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR and Pharmacophore Mapping Studies on Benzothiazinimines to Relate their Structural Features with anti-HIV Activity.
    Geethaavacini G; Poh GP; Yan LY; Deepashini R; Shalini S; Harish R; Sureshkumar K; Ravichandran V
    Med Chem; 2018; 14(7):733-740. PubMed ID: 29807521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.
    Fletcher DS; Candelore MR; Grujic D; Lowell BB; Luell S; Susulic VS; Macintyre DE
    J Pharmacol Exp Ther; 1998 Nov; 287(2):720-4. PubMed ID: 9808702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.